PATH-03. DIFFERENCES IN CLINICAL COURSE OF GROUP-A AND GROUP-B POSTERIOR FOSSA EPENDYMOMA (PFA, PFB) AS DEFINED BY H3K27ME3 IMMUNOHISTOCHEMICAL ANALYSIS

PURPOSE: Posterior fossa ependymoma is classified as PFA and PFB based on underlying genetic/mutational characteristics, and PFA is reported to have poor prognosis compared to PFB. Recently, immunohistochemical findings of negative H3K27me3 have been reported to suggest PFA and attracted the attenti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Yonezawa, Ushio, Yamasaki, Fumiyuki, takano, Motoki, Taniguchi, Hiroki, Sugiyama, Kazuhiko, Kurisu, Kaoru
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Molecular Pathology and Classification - Adult and Pediatric
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846923/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.599
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars